Juvenile Dermatomyositis

University Hospital, Strasbourg, France22 enrolled

Overview

This is a retrospective descriptive cross-sectional and observational multicenter clinical and progressive study of juvenile dermatomyositis. The aim is to determine the clinical, paraclinical, and evolutive characteristics and therapeutic modalities from a series of juvenile dermatomyositis identified in Alsace between 2000 to 2015.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Juvenile Dermatomyositis

Eligibility

Sex: ALLMin age: 1 DayMax age: 16 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Age under 16 years * Have a dermatomyositis according to the diagnostic criteria of Bohan and Peter of 1975 Exclusion Criteria: * Refusal to participate in the study

Locations (1)

Service de Dermatologie

Strasbourg, France

RECRUITING

Outcomes

Primary Outcomes

Study of clinical characteristics of juvenile dermatomyositis

Time frame: The period from from January 1st, 2000 to December 31st, 2015 will be examined

Central Contacts

Dan LIPSKER, MD, PhD

CONTACT

33.3.88.11.61.79 dan.lipsker@chru-strasbourg.fr

Céline RAMSTEIN, MD

CONTACT

33.3.88.11.61.79 celine.ramstein@chru-strasbourg.fr

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.